Mettler-Toledo International (NYSE:MTD – Get Rating) and Nautilus Biotechnology (NASDAQ:NAUT – Get Rating) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.
Institutional and Insider Ownership
91.9% of Mettler-Toledo International shares are owned by institutional investors. Comparatively, 45.3% of Nautilus Biotechnology shares are owned by institutional investors. 2.8% of Mettler-Toledo International shares are owned by company insiders. Comparatively, 41.3% of Nautilus Biotechnology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Get Mettler-Toledo International alerts:Profitability
This table compares Mettler-Toledo International and Nautilus Biotechnology's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Mettler-Toledo International | 21.48% | 1,929.28% | 26.15% |
| Nautilus Biotechnology | N/A | -17.79% | -16.17% |
Analyst Ratings
This is a summary of current recommendations and price targets for Mettler-Toledo International and Nautilus Biotechnology, as provided by MarketBeat.com.| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Mettler-Toledo International | 0 | 4 | 2 | 0 | 2.33 |
| Nautilus Biotechnology | 0 | 2 | 0 | 0 | 2.00 |
Mettler-Toledo International currently has a consensus price target of $1,356.00, indicating a potential downside of 6.19%. Nautilus Biotechnology has a consensus price target of $4.00, indicating a potential upside of 122.22%. Given Nautilus Biotechnology's higher probable upside, analysts plainly believe Nautilus Biotechnology is more favorable than Mettler-Toledo International.
Valuation and Earnings
This table compares Mettler-Toledo International and Nautilus Biotechnology's revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Mettler-Toledo International | $3.72 billion | 8.67 | $768.98 million | $36.54 | 39.56 |
| Nautilus Biotechnology | N/A | N/A | -$50.31 million | ($0.49) | -3.67 |
Mettler-Toledo International has higher revenue and earnings than Nautilus Biotechnology. Nautilus Biotechnology is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
Mettler-Toledo International has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. Comparatively, Nautilus Biotechnology has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500.
Summary
Mettler-Toledo International beats Nautilus Biotechnology on 11 of the 13 factors compared between the two stocks.
About Mettler-Toledo International
(Get Rating)
Mettler-Toledo International Inc. engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection, x-ray, checkweighing, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of networked scales and software, stand-alone scales, and automated packaging and labeling solutions for handling fresh goods. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. The company was incorporated in 1991 and is based in Columbus, Ohio.
About Nautilus Biotechnology
(Get Rating)
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.